Fund detail
HHLR Advisors / Hillhouse (Zhang Lei)
china, growth, hillhouse, active
Quarters
30
2019-12-31
$8.03B
Positions
54
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ALIGN TECHNOLOGY INC ALGN | $656.7M | 8.18% | 2,353,591 | +788,091 | +50.34% | 3.89% | 2019-09-30 | $279 | ~$197 | +41.40% | |
| 2 | UBER TECHNOLOGIES INC UBER | $461.0M | 5.74% | 15,501,624 | +3,175,105 | +25.76% | 5.16% | 2019-09-30 | $30 | ~$30 | -2.16% | |
| 3 | FIBROGEN INC FGENEUR | $169.7M | 2.11% | 3,955,787 | +452,500 | +12.92% | 1.78% | 2018-12-31 | $43 | ~$45 | -5.04% | |
| 4 | BLUEPRINT MEDICINES CORP 2655787D | $120.5M | 1.50% | 1,504,599 | +6,083 | +0.41% | 1.51% | 2018-12-31 | $80 | ~$55 | +46.75% | |
| 5 | KINIKSA PHARMACEUTICALS LTD | $21.0M | 0.26% | 1,895,888 | +28,266 | +1.51% | 0.22% | 2018-12-31 | $11 | ~$26 | -58.02% | |
| 6 | AKERO THERAPEUTICS INC AKRO | $19.8M | 0.25% | 891,201 | +141,777 | +18.92% | 0.23% | 2019-06-30 | $22 | ~$20 | +9.15% |